Localization of enteroviral antigen in myocardium and other tissues from patients with heart muscle disease by an improved immunohistochemical technique

被引:37
作者
Zhang, HY
Li, YW
Peng, TQ
Aasa, M
Zhang, L
Yang, YZ
Archard, LC
机构
[1] Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, Mol Pathol Sect, London SW7 2AZ, England
[2] Univ London Imperial Coll Sci Technol & Med, Div Invest Sci, London SW7 2AZ, England
[3] Shanghai Med Univ, Zhongshan Hosp, Minist Publ Hlth, Key Lab Viral Heart Dis, Shanghai 200032, Peoples R China
关键词
enterovirus; antigen; myocarditis; cardiomyopathy; immunohistochemistry; monoclonal antibody; EnVision;
D O I
10.1177/002215540004800501
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The association of enterovirus infection and heart muscle diseases has been investigated extensively by detection of viral genomic RNA using nucleic acid hybridization and the reverse transcription-polymerase chain reaction. To further understand the role of enterovirus and its persistence in these diseases, an immunohistochemical technique was optimized to investigate the expression of viral capsid proteins in situ. A monoclonal antibody (5-D8/1) against an epitope in the N-terminus of capsid protein VP1, conserved in the enterovirus genus, was employed. To enhance sensitivity, the EnVison system was used to detect antigen-antibody complex. VP1 was detected in formalin-fixed, paraffin-embedded endomyocardial biopsy or postmortem myocardial tissues and in liver, spleen, lung, kidney, and pancreas from patients with myocarditis or dilated cardiomyopathy, but not from controls. VP1 was localized in cytoplasm of myofibers, often adjacent to necrosis and infiltrate in myocarditis, and was clustered or scattered in dilated cardiomyopathy. This technique can be used for a definitive laboratory diagnosis of enterovirus-associated diseases and for studying the mechanisms of virus persistence in chronic myocardial disease.
引用
收藏
页码:579 / 584
页数:6
相关论文
共 23 条
[1]   Enteroviral infection causing fatal myocarditis and subclinical myopathy [J].
Arbustini, E ;
Porcu, E ;
Bellini, O ;
Grasso, M ;
Pilotto, A ;
Dal Bello, B ;
Morbini, P ;
Diegoli, M ;
Gavazzi, A ;
Specchia, G ;
Tavazzi, L .
HEART, 2000, 83 (01) :86-90
[2]   Characterization of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products [J].
Archard, LC ;
Khan, MA ;
Soteriou, BA ;
Zhang, HY ;
Why, HJF ;
Robinson, NMK ;
Richardson, PJ .
HUMAN PATHOLOGY, 1998, 29 (06) :578-584
[3]  
Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3
[4]   Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy [J].
Badorff, C ;
Lee, GH ;
Lamphear, BJ ;
Martone, ME ;
Campbell, KP ;
Rhoads, RE ;
Knowlton, KU .
NATURE MEDICINE, 1999, 5 (03) :320-326
[5]  
BOWLES NE, 1986, LANCET, V1, P1120
[6]   A SEARCH FOR THE PRESENCE OF THE ENTEROVIRAL CAPSID PROTEIN VP-1 IN PANCREASES OF PATIENTS WITH TYPE-1 (INSULIN-DEPENDENT) DIABETES AND PANCREASES AND HEARTS OF INFANTS WHO DIED OF COXSACKIEVIRAL MYOCARDITIS [J].
FOULIS, AK ;
FARQUHARSON, MA ;
CAMERON, SO ;
MCGILL, M ;
SCHONKE, H ;
KANDOLF, R .
DIABETOLOGIA, 1990, 33 (05) :290-298
[7]  
HUMMELER K, 1958, J IMMUNOL, V81, P499
[8]   DETECTION OF ENTEROVIRUS RNA IN MYOCARDIAL BIOPSIES FROM PATIENTS WITH MYOCARDITIS AND CARDIOMYOPATHY USING GENE AMPLIFICATION BY POLYMERASE CHAIN-REACTION [J].
JIN, O ;
SOLE, MJ ;
BUTANY, JW ;
CHIA, WK ;
MCLAUGHLIN, PR ;
LIU, P ;
LIEW, CC .
CIRCULATION, 1990, 82 (01) :8-16
[9]  
KANDA T, 1995, J MED, V26, P153
[10]   Pathogenesis of murine enterovirus myocarditis: Virus dissemination and immune cell targets [J].
Klingel, K ;
Stephan, S ;
Sauter, M ;
Zell, R ;
McManus, BM ;
Bultmann, B ;
Kandolf, R .
JOURNAL OF VIROLOGY, 1996, 70 (12) :8888-8895